Starton Therapeutics

Starton Therapeutics

Verified
Pharmaceutical company working on a proprietary transdermal delivery platform.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$374m (Public information from Apr 2023)
New York City New York (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
N/A

$0.0

round
investor

$0.0

Valuation: $0.0

round
N/A

$0.0

round
*
N/A

$3.4m

Post IPO Equity
Total Funding000k

Recent News about Starton Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.